ChemoCommunity

Characterizing chemoresponse communities at transcriptional and post-transcriptional levels.

Compound Details

The detailed records of NSC 670804 were elucidated in the following 4 sections: 1) Basis: basic information about NSC 670804; 2) Community: the network communities that were significantly associated with the response to NSC 670804; 3) Molecule: the relationships between components within communities and NSC 670804; 4) MDR: the compounds that were significantly associated with the NSC 670804.

NSC Compound Enrichment Correlation
NSC 672304 Null 0.0392716453377535 -0.033306396
NSC 680934 Null 0.0392716453377535 0.26799106
NSC 684906 Null 0.0392716453377535 0.14179432
NSC 692303 2,3-Dihydro-3(R)-[4'hydroxyphenylsulfinyl]brefeldin A 0.0392716453377535 -0.034901918
NSC 717953 Null 0.0392716453377535 0.59693533
NSC 718781 Erlotinib hydrochloride 0.0392716453377535 -0.11608093
NSC 719667 7-methoxy-8-[3-(1,4-oxazinan-4-yl)propoxy-(11aS)-2,3,5,11a -tetrahydro-1H-pyrrolo[2,1-c][1,4]benzodiazepine-5-one 0.0392716453377535 0.016216431
NSC 720134 Null 0.0392716453377535 -0.11861317
NSC 720320 1,6-bis-(2,6-difluorobenzyl)-2-(2,6-difluorophenyl)-5-methoxy-benzimidazole 0.0392716453377535 0.18286956
NSC 726217 Combretastatin A4-analogue 0.0392716453377535 -0.0080159378
Total:32  Current:24    [First] [Prev] [Next] [Last]